Elevated levels of reactive oxygen species (ROS) have commonly been implicated in a
variety of diseases, including cancer, inflammation, and neurodegenerative diseases. In …

Drug delivery systems, which use components at the nanoscale level as diagnostic tools or
to release therapeutic drugs to particular target areas in a regulated manner, are a fast …

Stimulus-responsive therapy that allows precise imaging-guided therapy is limited for
osteoarthritis (OA) therapy due to the selection of proper physiological markers as stimulus …

Increased levels of reactive oxygen species (ROS) have been associated with numerous
pathophysiological conditions including cancer and inflammation and the ROS stimulus …

Osteoarthritis (OA) is always characterized as excessive reactive oxygen species (ROS)
inside articular cavity. Mimicking natural metalloenzymes with metal ions as the active …

Reactive oxygen species (ROS) consist of a diverse range of oxidative small molecular ions
and free radicals that are produced throughout the body during certain biological processes …

Multifunctional nanomedicines with active targeting and stimuli-responsive drug release
function utilizing pathophysiological features of the disease are regarded as an effective …

Owing to its intricate autoimmune pathophysiology and significant risks of progression to
other rheumatic co-morbidities (ie, osteoporosis and osteoarthritis), a plausible therapeutic …

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint synovial
inflammation, as well as cartilage and bone tissue destruction. Current strategies for the …

Prodrug strategy is critical for innovative drug development. Structural modification is the
most straightforward and effective method to develop prodrugs. Improving drug defects and …